Sedation for stereotactic headframe application: a randomized comparison of two techniques.
A prospective, randomized study was performed in 87 patients to compare the safety, efficacy and dose requirements of two sedation techniques for stereotactic headframe application. Sedation administration and headframe application averaged 30 min. Fifty patients weighing 76 +/- 13 kg (mean +/- SD) received mean doses of 154 micrograms fentanyl plus 5.5 mg droperidol i.v. (FD group). An additional 37 patients weighing 76 +/- 19 kg received mean doses of 127 micrograms fentanyl plus 6.7 mg Valium (diazepam; FV group). Both treatments provided excellent hemodynamic stability and a low incidence of adverse side effects while providing adequate analgesia and sedation. The incidence of anesthetist-assessed patient anxiety and discomfort was more favorable in the FD group.
Lanier
W L
WL
Department of Anesthesiology, Mayo Clinic, Rochester, Minn.
Hool
G J
GJ
Faust
R J
RJ
Cucchiara
R F
RF
Kelly
P J
PJ
D000293:Adolescent; D000328:Adult; D000368:Aged; D003975:Diazepam / Q000627:therapeutic use*; D004329:Droperidol / Q000627:therapeutic use*; D005260:Female; D005283:Fentanyl / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D011229:Preanesthetic Medication; D011446:Prospective Studies; D011897:Random Allocation; D013238:Stereotaxic Techniques
D004329:Droperidol; D003975:Diazepam; D005283:Fentanyl